[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR950703530A - 5-HT4 길항제(5-HT4 Antagonists) - Google Patents

5-HT4 길항제(5-HT4 Antagonists)

Info

Publication number
KR950703530A
KR950703530A KR1019950701188A KR19950701188A KR950703530A KR 950703530 A KR950703530 A KR 950703530A KR 1019950701188 A KR1019950701188 A KR 1019950701188A KR 19950701188 A KR19950701188 A KR 19950701188A KR 950703530 A KR950703530 A KR 950703530A
Authority
KR
South Korea
Prior art keywords
antagonists
Prior art date
Application number
KR1019950701188A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929220508A external-priority patent/GB9220508D0/en
Priority claimed from GB929221774A external-priority patent/GB9221774D0/en
Priority claimed from GB929221791A external-priority patent/GB9221791D0/en
Priority claimed from GB929223135A external-priority patent/GB9223135D0/en
Priority claimed from GB929223138A external-priority patent/GB9223138D0/en
Priority claimed from GB929224604A external-priority patent/GB9224604D0/en
Priority claimed from GB939309642A external-priority patent/GB9309642D0/en
Priority claimed from GB939311878A external-priority patent/GB9311878D0/en
Application filed filed Critical
Publication of KR950703530A publication Critical patent/KR950703530A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1019950701188A 1992-09-29 1995-03-28 5-HT4 길항제(5-HT4 Antagonists) KR950703530A (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB929220508A GB9220508D0 (en) 1992-09-29 1992-09-29 Pharmaceuticals
GB929221774A GB9221774D0 (en) 1992-10-16 1992-10-16 Pharmaceuticals
GB929221791A GB9221791D0 (en) 1992-10-16 1992-10-16 Pharmaceuticals
GB929223135A GB9223135D0 (en) 1992-11-05 1992-11-05 Pharmaceuticals
GB929223138A GB9223138D0 (en) 1992-11-05 1992-11-05 Pharmaceuticals
GB929224604A GB9224604D0 (en) 1992-11-24 1992-11-24 Pharmaceuticals
GB939309642A GB9309642D0 (en) 1993-05-11 1993-05-11 Pharmaceuticals
GB939311878A GB9311878D0 (en) 1993-06-09 1993-06-09 Pharmaceuticals
PCT/GB1993/002028 WO1994007859A1 (en) 1992-09-29 1993-09-28 5-ht4 antagonists

Publications (1)

Publication Number Publication Date
KR950703530A true KR950703530A (ko) 1995-09-20

Family

ID=27571305

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701188A KR950703530A (ko) 1992-09-29 1995-03-28 5-HT4 길항제(5-HT4 Antagonists)

Country Status (10)

Country Link
US (1) US5696129A (ko)
EP (1) EP0662959A1 (ko)
JP (1) JPH08502056A (ko)
KR (1) KR950703530A (ko)
CN (1) CN1092766A (ko)
AU (1) AU4830593A (ko)
CA (1) CA2145746A1 (ko)
MX (1) MX9305947A (ko)
NZ (1) NZ256104A (ko)
WO (1) WO1994007859A1 (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
WO1994008965A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
FR2799757B1 (fr) * 1999-10-15 2001-12-14 Adir Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10143079A1 (de) * 2001-09-03 2003-05-15 Zentaris Ag Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
MXPA03000145A (es) * 2002-01-07 2003-07-15 Pfizer Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4.
CA2479205A1 (en) * 2002-03-28 2003-10-09 Eisai Co., Ltd. Azaindoles as inhibitors of c-jun n-terminal kinases
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
ATE388146T1 (de) * 2004-01-29 2008-03-15 Pfizer 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
AU2005254800B2 (en) 2004-06-15 2010-12-09 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
JP5042028B2 (ja) * 2004-11-05 2012-10-03 セラヴァンス, インコーポレーテッド キノリノン−カルボキサミド化合物
WO2006052640A1 (en) * 2004-11-05 2006-05-18 Theravance, Inc. 5-ht4 receptor agonist compounds
EP1831211B1 (en) * 2004-12-22 2010-06-02 Theravance, Inc. Indazole-carboxamide compounds
EA013567B1 (ru) * 2005-03-02 2010-06-30 Тереванс, Инк. Хинолиноновые соединения в качестве агонистов рецептора 5-ht

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
WO1993002677A1 (en) * 1991-08-03 1993-02-18 Smithkline Beecham Plc 5-ht4 receptor antagonists
AU2491092A (en) * 1991-09-12 1993-04-05 Smithkline Beecham Plc Azabicyclic compounds as 5-ht4 receptor antagonists
WO1993008187A1 (en) * 1991-10-24 1993-04-29 Smithkline Beecham Plc Imidazopyridines and indolizines as 5-ht4 antagonists
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
ATE180785T1 (de) * 1992-03-12 1999-06-15 Smithkline Beecham Plc Kondensierte indol-derivate als 5-ht4-rezeptor- antagonisten

Also Published As

Publication number Publication date
NZ256104A (en) 1996-11-26
MX9305947A (es) 1994-06-30
CN1092766A (zh) 1994-09-28
JPH08502056A (ja) 1996-03-05
AU4830593A (en) 1994-04-26
WO1994007859A1 (en) 1994-04-14
CA2145746A1 (en) 1994-04-14
EP0662959A1 (en) 1995-07-19
US5696129A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
NO922112D0 (no) Bicykliske rapamyciner
DE69311185D1 (de) Verbinder
DE69304176D1 (de) Verbinder
DK0738150T3 (da) Bicykliske fibrinogene antagonister
KR950703530A (ko) 5-HT4 길항제(5-HT4 Antagonists)
DE69320598D1 (de) Verbinder
DK163889D0 (da) Sproejteindretning
DE4392971T1 (de) Zyklonabschneider
DE69323147D1 (de) Verbinder
MX9100717A (es) Antagonistas de la bradiquinina
ITUD930257A0 (it) Alesatore meccanico
DE69315043D1 (de) Verbinder
ATE172738T1 (de) Substituierte 6-aza-androstenone
FI952804A (fi) Substituoidut bentsatsepinonit
DE69328466D1 (de) Verbinder
DE69301589D1 (de) Verbinder
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
DE69311024D1 (de) Verbinder
ATA151292A (de) Beschlag
FI930108A (fi) Imidazopyridin-paf-antagonister
FI91435B (fi) Parveke
DE59310082D1 (de) Substituierte 2-arylpyrrole
FI934864A0 (fi) Bicykliska karbamater
DE69315304D1 (de) Verbinder
KR950701618A (ko) 치환된 이소인돌론(Substituted Isoindolones)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid